Mandate

Vinge advises the shareholders of OptiGroup AB in connection with the divestment to FSN Capital

Vinge advises the shareholders of OptiGroup AB in connection with the divestment of a majority shareholding to FSN Capital. Current majority shareholders Triton, Altor and RoosGruppen will retain a minority holding in the company.

Headquartered in Mölndal, Sweden, OptiGroup is a leading European distribution group with presence in 16 countries that provides customised supply solutions to more than 90,000 B2B customers. The companies in the group’s three business areas Facility, Safety & Foodservice, Packaging and Paper and Business Supplies offer reliable and sustainable supply solutions for players in the cleaning and facility management, hotel and restaurant, health and medical care, manufacturing industry and the graphic sector.

The transaction is subject to applicable competition law approvals.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Elsie Nassar, Nando Basic and Egil Svensson (M&A), Jolinn Uhlin (Banking and Finance), Isabell Nielsen and Mario Saad (Commercial Agreements), Gustav Lindgren (Employment), Mathilda Persson and Martin Boström (IT), Karl-Hugo Engdahl (GDPR), Sofia Bergenstråhle (Intellectual Property), Kristoffer Larson (Real Property), Lina Österberg (Environmental Law), Tove Lövgren Frisk (Compliance) and Viktoria Owetz (VDR Specialist) and Jasmina Skandrani (Project Assistant).

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Advania in connection with the acquisition of atNorth HPC AB

Vinge has advised Advania, one of the leading IT companies in the Nordic region, in connection with the acquisition of atNorth HPC AB. The acquisition strengthens Advania's presence within high-performance computing (HPC).
October 03, 2025